Arthritis & Rheumatism

Arthritis & Rheumatism

Strong genetic component of fibromyalgia suggested

(HealthDay)—A genome-wide linkage scan has identified the chromosome 17p11.2-q11.2 region as the susceptibility locus for fibromyalgia, according to research published in the April issue of Arthritis & Rheumatism.

Arthritis & Rheumatism

'Mobility shoes' take a load off for knee osteoarthritis sufferers

New research suggests that patients with knee osteoarthritis (OA) who wear flat, flexible footwear (mobility shoes) had significant reduction in knee loading—the force placed upon the joint during daily activities. Results ...

Arthritis & Rheumatism

Double-jointed adolescents at risk for joint pain

A prospective study by U.K. researchers found that adolescents who are double-jointed—medically termed joint hypermobility—are at greater risk for developing musculoskeletal pain as they get older, particularly in the ...

Arthritis & Rheumatism

Brain activity linked to TNF inhibitor response in RA

(HealthDay)—Patients with rheumatoid arthritis who respond to tumor necrosis factor inhibitors (TNFi) show changes in activity in pain-related areas of the brain before clinical signs of improvement are observed, according ...

Diseases, Conditions, Syndromes

Naltrexone linked to reduction in pain in fibromyalgia

(HealthDay)—Low-dose naltrexone treatment is associated with significant reductions in pain in patients with fibromyalgia, according to a study published in the February issue of Arthritis & Rheumatism.

Arthritis & Rheumatism

Simple intervention ups pneumococcal vaccination rate

(HealthDay)—Use of a simple point-of-care paper reminder form is associated with an increase in the percentage of immunosuppressed rheumatology patients who remain up-to-date with their pneumococcal vaccinations, according ...

Arthritis & Rheumatism

Predictors of organ damage identified in patients with SLE

(HealthDay)—Patient age, hypertension, and corticosteroid use are the most important predictors of the cumulative organ damage that occurs in patients with systemic lupus erythematosus (SLE), according to research published ...

Arthritis & Rheumatism

Immunogenicity strongly impacts response to adalimumab in RA

(HealthDay)—For patients with rheumatoid arthritis (RA), long-term clinical outcomes are good with etanercept and adalimumab; but for adalimumab, treatment response is strongly dependent on the presence or absence of anti-adalimumab ...

page 3 from 6